This 3-hour virtual course emphasises the progress made in developing novel immunotherapies for solid tumours, such as CAR T cell therapy, TCR-engineered T cell therapy, tumour infiltrating lymphocytes, T cell engagers, and vaccine-based treatments.
This course gives cancer nurses and trial staff the knowledge and confidence to discuss a wide range of targeted cancer treatments and immunotherapies with patients and colleagues.